Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study
达格列净和吡格列酮联合治疗伴或不伴MASLD的2型糖尿病——系统评价和荟萃分析:PRO-2研究
期刊:Frontiers in Clinical Diabetes and Healthcare
影响因子:3.500
doi:10.3389/fcdhc.2026.1733995
Joshi, Shashank; Samajdar, Shambo Samrat; Gupta, Arvind; Bhartia, Mithun; Lodha, Sailesh; Bhattacharyya, Supratik; Seshadri, Krishna; Nagendra, Lakshmi; Unnikrishnan, A G; Padhye, Dakshata; Kopalle, Lakshmi Nalini; Das, Ashok Kumar; Lakhani, Om; Kesavadev, Jothydev; Joshi, Ameya; Das, Sambit; Gadia, Smriti; Anthuvan, Thamburaj